The Cancer Therapeutics Research Group (CTRG) was formed in October 1997 by Professor John Wong (National University Health System) and Professor James Bishop (Sydney Cancer Centre and University of Sydney) to develop new therapeutic strategies for cancers common to Asia-Pacific.

This resulted in a joint research group which performs clinical trials on new anti-cancer drugs in Asia-Pacific, and aims to be the equivalent of oncology cooperative groups in the USA.

The CTRG has rapidly established itself and is now recognised as the leading group for evaluating new therapeutic strategies in the Asia-Pacific region.

1. To provide the means and opportunity to test promising new compounds and therapeutic strategies simultaneously in Asian and Caucasian patients with cancer.
2. To study pharmacogenomics in relation to ethnicity.
3. To develop better therapies for cancers common in Asia and the Pacific.
4. To provide high quality, credible and reliable data through ICH-GCP compliant clinical trials for rapid registration and licensing of new compounds in Asia.